MedPath

Investigating the effectiveness of using cellular and acellular amniotic membrane in the treatment of foot ulcers in patients with diabetes: Phase 1 and 2 randomized clinical trial

Phase 1
Recruiting
Conditions
diabetes.
Diabetes mellitus due to underlying condition
Registration Number
IRCT20210422051040N2
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

The presence of diabetic foot ulcer criteria
The wound area is more than 2 cm2 and less than 5 cm2
The patient does not have HIV, HBV, HCV, HTLV1 viral infections
The patient does not have an acute bacterial infection
Adherence to medication regimen by diabetic patients

Exclusion Criteria

Abuse of drugs and alcohol
Acute bacterial infection and sepsis
Cancer and use of cytotoxic drugs
Severe vascular diseases, lupus, rheumatoid arthritis, kidney failure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Wound surface. Timepoint: 30 day. Method of measurement: Imaging of the wound surface.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath